Optimal two-stage designs based on restricted mean survival time for a single-arm study
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference32 articles.
1. Alternatives to hazard ratios for comparing the efficacy or safety of therapies in noninferiority studies;Uno;Ann. Intern. Med.,2015
2. Predicting the restricted mean event time with the subject's baseline covariates in survival analysis;Tian;Biostatistics,2014
3. Restricted mean survival time for interval-censored data;Zhang;Stat. Med.,2020
4. Statistical test/estimation methods used in contemporary phase III cancer randomized controlled trials with time-to-event outcomes;Uno;Oncol.,2020
5. An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use;Calkins;BMC Med. Res. Methodol.,2018
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Two-stage response adaptive randomization designs for multi-arm trials with binary outcome;Journal of Biopharmaceutical Statistics;2023-07-15
2. Continuity Corrected Wilson Interval for the Difference of Two Independent Proportions;Journal of Statistical Theory and Applications;2023-04-01
3. Response adaptive randomization design for a two-stage study with binary response;Journal of Biopharmaceutical Statistics;2023-02-03
4. Effects of dose change on the success of clinical trials;Contemporary Clinical Trials Communications;2022-12
5. Monte Carlo cross-validation for a study with binary outcome and limited sample size;BMC Medical Informatics and Decision Making;2022-10-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3